0.457
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Oncology Pharma Inc (PK) | ONPH | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.457 | 16:25:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.457 | 0.457 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.376 | 1.50 | 1.12 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 2 | 20 | - | 0.00395 - 0.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:21:02 | 10 | $ 0.356 | USD |
Oncology Pharma (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 11.49M | 25.13M | 3.39M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.20k | $ - | 0.00% | - | - |
Oncology Pharma (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONPH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.42 | 0.85 | 0.42 | 0.4857628 | 1,545 | 0.037 | 8.81% |
| 1 Month | 0.5567 | 0.85 | 0.42 | 0.4685266 | 1,195 | -0.0997 | -17.91% |
| 3 Months | 0.41 | 0.85 | 0.25 | 0.4888688 | 1,354 | 0.047 | 11.46% |
| 6 Months | 0.0093 | 0.85 | 0.00395 | 0.0107375 | 91,253 | 0.4477 | 4,813.98% |
| 1 Year | 0.019 | 0.85 | 0.00395 | 0.0208982 | 306,157 | 0.438 | 2,305.26% |
| 3 Years | 0.01 | 0.85 | 0.003 | 0.0263887 | 268,645 | 0.447 | 4,470.0% |
| 5 Years | 0.01 | 0.85 | 0.003 | 0.0263887 | 268,645 | 0.447 | 4,470.0% |
Oncology Pharma (PK) Description
| Oncology Pharma, Inc. is a pioneering oncology company dedicated to licensing, developing, manufacturing and commercializing therapeutics. The Company has assembled a team of executives and advisors with a proven multi-disciplinary expertise in the field of cancer therapies and leadership to identify, negotiate and amalgamate "best in class" research, technologies, and drug delivery that are synergistic and collaborative. Oncology Pharma has executed Letters of Intent with Kalos Therapeutics, with its lead anti-cancer bio-pharmaceutical (a peptide) medication, KTH-222. NanoSmart Pharmaceuticals' drug delivery platform can target many types of cancer and other diseases. Connect2Med, a powerful application used for recruiting, enrolling and supporting patients for clinical trials. Finally, the Company has entered into a Letter of Intent to acquire a 50% stake in Diagnomics, Inc., which is a "cutting edge" molecular diagnostic company in precision medicine, a CLIA and CAP accredited Laboratory that among other uses provides services to global pharmaceutical companies, including academic and biotech companies in San Diego, CA. Diagnomics' use of pharmacogenetics combined with artificial intelligence is a "game changer" in precision medicine, drug development, clinical trials, lowering of cost and time of clinical trials, a faster regulatory approval process and faster availability of drugs to the patients. Further information may be found at www.oncology-pharma.com. |
